Abstract
The incidence of breast cancer has been on the rise in the United States over the past several decades. The advanced longevity of the population during this same time period, specifically of elderly women, translates to increases in the absolute number of women diagnosed with breast cancer yearly. This, in combination with decreasing mortality rates, has now led to an increase in the number of breast cancer survivors who need long-term follow-up. There has been significant debate over what tests should be obtained, how often they should be obtained, how long surveillance should be continued, and by whom this should be performed. We review the published guidelines for surveillance, available data regarding low- versus high-intensity surveillance plans, current practice patterns, and recommendations for future strategies.
References
American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2012.
Ries LAG, Melbert D, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2005. Bethesda: National Cancer Institute; 2007. http://seer.cancer.gov/csr/1975_2005/. Accessed 21 May 2013.
NCCN clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#breast. Accessed 4 Sept 2013.
Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2005;1:CD001768.
Khatcheressian JL, Wolff AC, Smith TJ, et al.; American Society of Clinical Oncology. 2006 Update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–7.
The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA. 1994;271:1587–92.
Del Turco RM, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA. 1994;271:1593–7.
Tomin R, Donegan WL. Screening for recurrent breast cancer—its effectiveness and prognostic value. J Clin Oncol. 1987;5:62–7.
Dewar JA, Kerr GR. Value of routine follow-up for women treated for early carcinoma of the breast. Br Med J (Clin Res Ed). 1985;291:1464–7.
Donnelly J, Mack P, Donaldson LA. Follow-up of breast cancer: time for a new approach? Int J Clin Pract. 2001;55:431–3.
Margenthaler JA, Allam E, Chen L, Virgo KS, Kulkarni UM, Patel AP, Johnson FE. Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract. 2012;8:79–83.
Lindfors KK, Rosenquist CJ. The cost-effectiveness of mammographic screening strategies. JAMA. 1995;274:881–4.
Cady B. Cost-effective preoperative evaluation, operative treatment, and postoperative follow-up in the breast cancer patient. Surg Clin N Am. 1996;76:25–34.
Disclosures
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Margenthaler, J.A., Johnson, F.E. & Cyr, A.E. Intensity of Follow-Up After Breast Cancer Surgery: Low Versus High?. Ann Surg Oncol 21, 733–737 (2014). https://doi.org/10.1245/s10434-013-3251-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-013-3251-8